Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,240 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.
根據最新的財務報表(Form-10K),Shandong Xinhua Pharmaceutical Co Ltd 的總資產為 $0,淨isProfitable}為 $0
SHNXY 的關鍵財務比率是什麼?
Shandong Xinhua Pharmaceutical Co Ltd 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Shandong Xinhua Pharmaceutical Co Ltd 的收入按細分市場或地理位置如何劃分?
Shandong Xinhua Pharmaceutical Co Ltd 주요 수익원은 Pharmaceutical Preparations이며, 최신 수익 발표에서 수익은 3,985,519,069입니다. 지역별로는 China (including Hong Kong)이 Shandong Xinhua Pharmaceutical Co Ltd의 주요 시장이며, 수익은 6,785,211,744입니다.
Shandong Xinhua Pharmaceutical Co Ltd 是否盈利?
no,根據最新的財務報表,Shandong Xinhua Pharmaceutical Co Ltd 的淨손실為 $0